Concepedia

Canadian Cardiovascular Society/Canadian Heart Failure Society Joint Position Statement on the Evaluation and Management of Patients With Cardiac Amyloidosis

Nowell M. Fine, Margot K. Davis, Kim Anderson, Diego Delgado, Geneviève Giraldeau, Abhijat Kitchlu, Rami Massie, Jane Jayvena Narayan, Elizabeth Swiggum, Christopher P. Venner,

Canadian Journal of Cardiology · 2020 · 111 citations · 47 references

DOI

Concepts

References

47

Patisiran, an RNAi Therapeutic, for Hereditary Transthyretin Amyloidosis

David Adams, Alejandra González‐Duarte, William O’Riordan et al. · New England Journal of Medicine · 2018 · 2.9K citations · Full text

, , +14

Tafamidis Treatment for Patients with Transthyretin Amyloid Cardiomyopathy

Jeffrey H. Schwartz, Balarama Gundapaneni, Perry Elliott et al. · New England Journal of Medicine · 2018 · 2.7K citations · Full text

, , +13

Nonbiopsy Diagnosis of Cardiac Transthyretin Amyloidosis

Julian D. Gillmore, Rodney H. Falk, Giampaolo Merlini et al. · Circulation · 2016 · 2K citations · Full text

, , +14

Inotersen Treatment for Patients with Hereditary Transthyretin Amyloidosis

Merrill D. Benson, Márcia Waddington‐Cruz, John L. Berk et al. · New England Journal of Medicine · 2018 · 1.4K citations · Full text

, , +16

Wild-type transthyretin amyloidosis as a cause of heart failure with preserved ejection fraction

Esther González-López, María Gallego‐Delgado, Gonzalo Guzzo-Merello et al. · European Heart Journal · 2015 · 1.1K citations · Full text

, , +14